An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
2d
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.
“People with diabetes and kidney disease are at very high risk of cardiovascular ... Bhatt said it may be because the drug also blocks the SGLT1 (sodium-glucose cotransporter 1) receptor as ...
Travere’s stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
The US recently approved clinical trials for pig kidney transplants, opening the door to the potential use of other organs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback